Stocktoria
Processa Pharmaceuticals, Inc. PCSA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-10-07
Processa Pharmaceuticals, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Young David | Pres. Research & Development | 2026-06-15 | Buy | 2,067 | $2.22 |
| SKIBSTED RUSSELL | Chief Financial Officer | 2026-06-15 | Buy | 2,654 | $2.22 |
| Ng George K | Chief Executive Officer | 2026-06-15 | Buy | 2,465 | $2.22 |
| Lin Patrick | Chief Business - Strategy Off | 2026-06-15 | Buy | 1,831 | $2.22 |
| Guy Wendy | Chief Administrative Officer | 2026-06-15 | Buy | 2,118 | $2.22 |
| Young David | Pres. Research & Development | 2026-05-29 | Buy | 1,786 | $2.57 |
| SKIBSTED RUSSELL | Chief Financial Officer | 2026-05-29 | Buy | 2,292 | $2.57 |
| Ng George K | Chief Executive Officer | 2026-05-29 | Buy | 2,129 | $2.57 |
Source: SEC EDGAR filings · CIK 0001533743 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.